McGill researchers are pioneering a new artificial pancreas system that provides life-changing support to people living with type 1 diabetes.
By Ashley Rabinovitch
Landmark Clinical Trial of a Novel Combination Treatment for Type 1 Diabetes Begins at Jewish General Hospital and McGill University Health Centre
Insulin has long been known as the hormone which controls the body’s sugar levels: humans who lack or are insensitive to insulin develop diabetes. Although insulin is also made and released in the brain, its effects there have remained unclear.